Published procurement activity · 1,388 tenders
Buyer information published with procurement notices.
There is currently no Return to Practice (RTP) Midwifery programme available in the East Midlands, creating a significant barrier for qualified midwives who want to return to the profession but are unable to travel long distances or relocate. To address this gap, a new RTP Midwifery programme is being developed to provide a loca
NHS England has awarded a contract to a competent and capable supplier to host the NHS Race and Health Observatory (NHS RHO).<br/>The appointed Host Supplier will support the delivery of an agreed programme of works that will bridge the gap in the stark race and ethnic health inequalities across the healthcare system.
The requirement is for outcomes-based deliverables to scope, design and build the appropriate data access and extraction and transfer to NHSE via the NHS Cyber API, as structured Measures, Metrics & Indicators, into the NHS Cyber Data Platform.
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizu
Education & Training contract with Keele University<br/><br/> https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Sr0000012G89/wn7njEyE0Nhi_VJrDnU58Qszr4D8vUdqGhlhlchR18k
An agreement with Academy of Healthcare Science to provide coaching and trauma leadership training to audiology staff in hearing services across England. This includes sessions on giving compassionate news to staff and patients and self-care as a consequence of difficult conversations.
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/
Provider to deliver in partnership an Older People's Sounding Board. This will help ensure across NHSE (and beyond) that we fulfil our statutory duties to involve people and communities. In particular it will enable older people to influence decision making, policy development, planning, services design and services review.
NHS National Generic Pharmaceuticals – Clozapine<br/><br/>Offer reference number: CM/PHG/22/5667<br/><br/>Period of framework agreement: 1st August 2025 to 31st July 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
Patient safety review of Advanced Practice ePortfolio (supported) Route
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.